大阪医科薬科大学薬学部 薬物治療学Ⅰ研究室
大阪医科薬科大学薬学部 
薬物治療学Ⅰ研究室Pharmacotherapeutics and Toxicology,
Osaka Medical and Pharmaceutical University

植村さん、大野さん、西本さん、田中先生が第22回国際TDM学会(IATDMCT)にて発表を行いました。

投稿日:

植村健矢さん(6年生)、大野友裕さん(6年生)、西本偉武貴さん(6年生)、田中先生が22nd International Congress of Therapeutic Drug Monitoring and Clinical Toxicology(IATDMCT,Banff, Canada)にてポスター発表を行いました。
演題名:
Sorafenib activates inflammasomes leading to sorafenib-induced immune related adverse events(植村さん)
Elucidation of the mechanism of amiodarone-induced immune related adverse reaction and search for biomarkers to predict its pathogenesis(大野さん)
Elucidation of the mechanism of gefitinib-induced immune related adverse reaction and search for biomarkers to predict its pathogenesis(西本さん)
The mechanism of flutamide induced liver injury via inflammasome activation(田中先生)

Kenya Uemura (6th grade), Tomohiro Ohno (6th grade), Weimuki Nishimoto (6th grade), and Jr. Assoc. Prof. Saori Tanaka gave poster presentations at the 22nd International Congress of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT, Banff, Canada).
Presentation Title:
Sorafenib activates inflammasomes leading to sorafenib-induced immune related adverse events(Kenya Uemura)
Elucidation of the mechanism of amiodarone-induced immune related adverse reaction and search for biomarkers to predict its pathogenesis(Tomohiro Ohno)
Elucidation of the mechanism of gefitinib-induced immune related adverse reaction and search for biomarkers to predict its pathogenesis(Ibuki Nishimoto)
The mechanism of flutamide induced liver injury via inflammasome activation(Saori Tanaka)

植村さん        大野さん        西本さん

page top